Ransom Advisory’s Amgen AMGN Stock Holding History

Ransom Advisory’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$632K	Buy	1,930 +67	+4%	+$21.3K	0.25%	71
2025 Q3	$526K	Hold	1,863	–	–	0.24%	69
2025 Q2	$520K	Hold	1,863	–	–	0.25%	70
2025 Q1	$580K	Sell	1,863 -200	-10%	-$59.1K	0.29%	67
2024 Q4	$538K	Buy	2,063 +300	+17%	+$89K	0.25%	77
2024 Q3	$568K	Hold	1,763	–	–	0.27%	73
2024 Q2	$551K	Buy	1,763 +76	+5%	+$22.3K	0.28%	71
2024 Q1	$480K	Buy	+1,687	New	+$494K	0.26%	83

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Ransom Advisory's AMGN Position: Q4 2025 in Review

Ransom Advisory increased its Amgen (AMGN) stake by 3.6% in Q4 2025, buying an estimated $21.3K and bringing the position to 1,930 shares worth $632K. The position accounts for 0.25% of the portfolio, ranked #71.

Ransom Advisory first reported a position in AMGN in Q1 2024 and has held it in 8 quarters since. 3,086 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

Ransom Advisory held 1,930 shares of Amgen worth $632K as of Q4 2025.
Ransom Advisory bought 67 Amgen shares in Q4 2025, an estimated $21.3K.
Amgen made up 0.25% of Ransom Advisory's portfolio in Q4 2025, its #71 holding.
Ransom Advisory first reported a position in Amgen in Q1 2024 and has held it in 8 quarters since.
3,086 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.